Stent coated with a sustained-release drug delivery and method for use thereof
US7279175B2 · kind B2 · utility
97Cited by
6References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2002 |
| Grant date | Oct 9, 2007 |
| Priority date | — |
| Expiry date | Apr 6, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/606
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An intraluminal medical device comprises a stent having a coating applied to at least part of an interior surface, an exterior surface, or both. The coating comprises a sustained release formulation of a combination of pharmaceutical compounds dispersed within a biologically tolerated polymer composition. The choice of the combination of pharmaceutical compounds are intended to reduce neointimal hyperplasia restenosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.